ãã«ã¼ã©ã¤ãæã¡ããã¦ãç¡ç ã®è³ªãä¸ããå¿
è¦ãããã¾ãã ãããç¾ä»£ã®ä¸ã®ä¸ã§å®å
¨ãªããã«ã¼ã©ã¤ãæã¡ãããã®ã¯ä¸å¯è½ã«è¿ãã ãã«ã¼ã©ã¤ãã«ããå½±é¿ãå°ãã§ãæ¸ããããããªåªåããã¦ã¿ã¾ãããã ãã«ã¼ã©ã¤ã対ç ãã«ã¼ã©ã¤ãã æè¿ã§ã¯å¥³æ§èªãªã©ã§ããã«ã¼ã©ã¤ããä¸ããæªå½±é¿ã«ã¤ãã¦ç¹éãããããã«ãªãã¾ããã ãã«ã¼ã©ã¤ããç®ã«æªãããã¨ããã®ã¯ä½ã¨ãªãåããã¨æãã¾ããããèã®èåã«ãå½±é¿ãä¸ããã£ã¦ãåç¥ã§ãããï¼ ¥ããã»ã¹éçºã¾ã§(第1å)ãã«ã¼ã©ã¤ãã«ããç¼ç²¾ç²å´ã¨èã®èåä¿é²ä½ç¨ é´æ¨ é«åº åå¦è£
ç½® 61(1), 72-76, 2019-01 å´ã®å¯è¦å
ãæããç¼ã®å½¹å²ã¯ä¸è¬ã« å¯è¦å
ã§ãã®ãè¦ããã¨ã ã¨èããã㦠ãã«ã¼ã©ã¤ããèã«æªå½±é¿ãåã¼ãããæ¥ç¼ãï¼ã¹ããç¼ãï¼ããè²ç´ æ²çãã®åå ã«ãªãããã¨ããã®ã¯æ¬å½ãªã®ã§ããããï¼ ãããããã«ã¼ã©ã¤ãã¨ã¯ãªããªã®ãããã³ã°uvaãªã©ã¨æ¯è¼ãã¤ã¤ããã«ã¼ã©ã¤ããèã«ä¸ããå½±é¿ã«ã¤ãã¦èãã¦ã¿ã¾ããã )ã«æ²è¼ãããã(è«æå: Clinical evaluation method for blue light (456 nm) protection of skin) è«æã»å°éèªè¨äº ç¾å¨è«æçºè¡¨æ°ç´¯è¨ 26å ±/å¼ç¨ä»¶æ°ç´¯è¨ 351件 ããã¾ã§ã«çºè¡¨ããç 究è«æã®ãªã¹ãã§ã â»é¡åãã¯ãªãã¯ããã¨è«æãã¼ã¿ãã¼ã¹ãµã¤ã(è±èªãµã¤ã)ã¸ãªã³ã¯ãã¾ã. å
è¿°ãã¾ããéãããã«ã¼ã©ã¤ãã¯ã»ãããã³ãæ´»æ§åããã¾ããã¤ã¾ãæ´»åããæé帯ã«ãã«ã¼ã©ã¤ããæµ´ã³ãã°ãæ´»çºã«åããã¨ãæå¾
ã§ãã¾ãã ããå®ãããã«ãæ°´ç´ ãæãå
¥ãããã¡ã¼ã¸ãæããå¿
è¦ãããã ã¯ãªã©èã®èåãä¿é²ãããã¨ãããã£ã¦ãã¦ãããå社ã§ã¯æ°ããªèèåã®è¦å ã«ãªã£ããã«ã¼ã©ã¤ã対ç製åã¨ãã¦ããã¾ãã¾ãªå粧åç¨éã«ææ¡ â¦ ãã ã¨ãããã¦ãããã§ãã æ¯æ¥ã¹ããããã½ã³ã³ã使ã£ã¦ããã¨å°ããªççãæ
¢æ§çãªãã®ã«ãªãã èã®ä¸ã§ãã¡ã¼ã¸ãã©ãã©ãèç© ã 2018å¹´ï¼3å ±ï¼ ãã»åãéã®ãã«ã¼ã©ã¤ãã¨èµ¤ãå
ããèã«å½ã¦ã¦åå¿ãæ¯ã¹ãããã§ãã (uv)ã©ã³ãã使ã£ã¦ããæ½è¨ããããè¦ããã¾ããæ¯å»è
ããã§ãã«ã¼ã®ã©ã¤ãã«ç
§ãããã¦ããã¹ãªããã¯ãã¾ãã«æ®ºèä¸ãªã®ã§ãï¼ ç¾ä»£äººã®ç¡ç ã®è³ªã«å¤§ããé¢ãã£ã¦ããã®ããã¹ãã¼ããã©ã³ãªã©ã®ç»é¢ããçºããããããã«ã¼ã©ã¤ããã§ããç¡ç ã®è³ªã®ä½ä¸ã¯ãç²å´å復ãèã®åçãªã©ã«å½±é¿ãä¸ããåå ã«ããªãã®ã§ãããã«ã¼ã©ã¤ããç¡ç ã«ä¸ããå½±é¿ããç´¹ä»ãã¾ãã æ ªå¼ä¼ç¤¾ ãããçæ´»ã®ãã¬ã¹ãªãªã¼ã¹ï¼2017å¹´3æ9æ¥ 18æ13åï¼ãã«ã¼ã©ã¤ããç®ã®ç¶²èç´°èã«åã¼ãæ°ããªå½±é¿ã解æï¼ 2006 Feb;84(1):4-15. ãã«ã¼ã©ã¤ãã¨ä¸ç çã«é¢ããè«æ Blocking nocturnal blue light for insomnia: A randomized controlled trial Algvere PV, Marshall J, Seregard S. Acta Ophthalmol Scand. µç«¯ ä¸æ Fragrance journal : Research & development for cosmetics, toiletries & allied industries = ãã¬ã°ã©ã³ã¹ã¸ã£ã¼ãã« : é¦ç²§åç§å¦ç 究éçºå°éèª 45(10), 42-48, 2017-10 ã«æªå½±é¿ãä¸ãã¦ãããã¨ãåºã¼ããããã¦ãã¾ãã ãã«ã¼ã©ã¤ãã®æªå½±é¿ãé¿ãã5ã¤ã®æ¹æ³ â ã¹ããããã½ã³ã³ã使ããªãæããåå¾3æã¾ã§. 翻訳対象ã¯ãã¼ã¸å
ã«è¨è¼ããã¦ããæåæ
å ±ã¨ãªãã¾ããç»åçã§è¡¨ç¾ããå
容ã¯ç¿»è¨³ããã¾ããã å粧ç¨ã³ããã³ã«ãããããã£ã³ã°ã®ã¹ãã³ã±ã¢å¹æ ä¹
çæ¸ çå¥ç¾ , æ²³é å¼ç¾ , å¡©å ã¿ãã , æ± ç° ç¥å , 竹å
ç´äºº , æ æ´é æ¥æ¬å粧åæè¡è
ä¼èª 45(4), 329-333, 2011 æéè¦ã¦ããæ¹å¿
è¦ï¼å°é家ã«ããã«ã¼ã©ã¤ããä½è
ã§ãä½ã©ã®ããã«å½±é¿ãã¦ããã®ã解説ããã ãã¾ããã ã©ããããºãã§ããæ¯æ¥ãã½ã³ã³ç»é¢ã¨ã«ããã£ãã§ç®ãã¤ãããããã«ã¼ã©ã¤ããªãã¨ããããããï¼ãã½ã³ã³ã1æ¥ä¸è¦ã¦ãã¨ç®ãããªãç²ãã¾ãããããã½ã³ã³ä½æ¥ã®å¤ãæ¹ã§ããã°ããã«ã¼ã©ã¤ãã«ããã®ã¡ã¬ããä½ãããã¨1度ã¯æ¤è¨ãããã¨ããããã¨æ ãã¨ãã«ã®ã¼ãæã£ã¦ãããè§èãæ°´æ¶ä½ã§å¸åãããã«ç¶²èã¾ã§å°éãã¾ãã ã©ã³ã³ã ã¯ãã®ã»ã©ãã¹ããã»pcãªã©ã®ç»é¢ããçºçããããã«ã¼ã©ã¤ãããèã«åã¼ãå½±é¿ã«ã¤ãã¦ã®ç 究çµæãçºè¡¨ããã ããèãã©ãã©ãèåãã¦ãããã¨ã«ãã æ¥æ¬ãã¬ã¢ã«æ ªå¼ä¼ç¤¾ã®ç 究ã«ãã£ã¦ããã«ã¼ã©ã¤ããèç´°èãå¤è²ããããã¨ãæããã«ã ãã«ã¼ã©ã¤ãã®å é½¢é»æå¤æ§ã¸ã®ãªã¹ã¯ Age-related maculopathy and the impact of blue light hazard. ä¸è¬çã«åºãç¥ãããããã«ãªã£ãããã«ã¼ã©ã¤ãããä½ã¨ãªãç®ã«æªãã¨ããã¤ã¡ã¼ã¸ã¯ãã£ã¦ããç®ã«ã©ã®ãããªå½±é¿ããããããã¯è©³ããç¥ããã¦ãã¾ããããã®ä¸æ¹ã§ããã«ã¼ã©ã¤ãã¯è¦åã«å½±é¿ããªããã¨ãã£ãæ
å ±ãé£ã³äº¤ã£ã¦ããããæ¬å½ã¯ã©ããªã®ï¼